ArticleOncotarget2017
Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
LingLong Peng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled itcites it
ArticleOncotarget2017
LingLong Peng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.